RU2587606C2 - Новый способ пцр-секвенирования и его применение в генотипировании hla - Google Patents
Новый способ пцр-секвенирования и его применение в генотипировании hla Download PDFInfo
- Publication number
- RU2587606C2 RU2587606C2 RU2013103795/10A RU2013103795A RU2587606C2 RU 2587606 C2 RU2587606 C2 RU 2587606C2 RU 2013103795/10 A RU2013103795/10 A RU 2013103795/10A RU 2013103795 A RU2013103795 A RU 2013103795A RU 2587606 C2 RU2587606 C2 RU 2587606C2
- Authority
- RU
- Russia
- Prior art keywords
- hla
- pcr
- sequencing
- dna
- primer
- Prior art date
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 256
- 238000000034 method Methods 0.000 title claims abstract description 174
- 238000003205 genotyping method Methods 0.000 title abstract description 70
- 230000003321 amplification Effects 0.000 claims abstract description 112
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 112
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims abstract description 84
- 108010075704 HLA-A Antigens Proteins 0.000 claims abstract description 76
- 238000013467 fragmentation Methods 0.000 claims abstract description 60
- 238000006062 fragmentation reaction Methods 0.000 claims abstract description 60
- 108010052199 HLA-C Antigens Proteins 0.000 claims abstract description 50
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims abstract description 49
- 238000004458 analytical method Methods 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 8
- 108020004414 DNA Proteins 0.000 claims description 188
- 108700024394 Exon Proteins 0.000 claims description 107
- 239000000203 mixture Substances 0.000 claims description 76
- 238000000746 purification Methods 0.000 claims description 53
- 238000001962 electrophoresis Methods 0.000 claims description 38
- 239000012634 fragment Substances 0.000 claims description 30
- 238000012408 PCR amplification Methods 0.000 claims description 29
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 28
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims description 25
- 108010039343 HLA-DRB1 Chains Proteins 0.000 claims description 25
- 238000001712 DNA sequencing Methods 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- 238000002955 isolation Methods 0.000 claims description 17
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 238000005520 cutting process Methods 0.000 claims description 15
- 101150046128 HLA-DQB1 gene Proteins 0.000 claims description 11
- 238000010276 construction Methods 0.000 claims description 11
- 238000011176 pooling Methods 0.000 claims description 10
- 238000002864 sequence alignment Methods 0.000 claims description 9
- 241000124008 Mammalia Species 0.000 claims description 5
- 230000006862 enzymatic digestion Effects 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 abstract description 46
- 108010065026 HLA-DQB1 antigen Proteins 0.000 abstract description 46
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 160
- 238000006243 chemical reaction Methods 0.000 description 48
- 238000005516 engineering process Methods 0.000 description 42
- 239000000499 gel Substances 0.000 description 36
- 101100284398 Bos taurus BoLA-DQB gene Proteins 0.000 description 24
- 239000013642 negative control Substances 0.000 description 23
- 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 21
- 102100038823 RNA-binding protein 45 Human genes 0.000 description 21
- 238000000605 extraction Methods 0.000 description 21
- 239000003550 marker Substances 0.000 description 18
- 108091035707 Consensus sequence Proteins 0.000 description 16
- 101150118346 HLA-A gene Proteins 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 12
- 238000007480 sanger sequencing Methods 0.000 description 12
- 239000011543 agarose gel Substances 0.000 description 11
- 239000007795 chemical reaction product Substances 0.000 description 11
- 230000004913 activation Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 238000003753 real-time PCR Methods 0.000 description 10
- 241001504639 Alcedo atthis Species 0.000 description 9
- 101150076489 B gene Proteins 0.000 description 9
- 238000004590 computer program Methods 0.000 description 9
- 101150035071 HLA-C gene Proteins 0.000 description 8
- 239000012149 elution buffer Substances 0.000 description 8
- 238000009004 PCR Kit Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 101150000578 HLA-B gene Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 102000054766 genetic haplotypes Human genes 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000002457 bidirectional effect Effects 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 101150028074 2 gene Proteins 0.000 description 2
- 101150090724 3 gene Proteins 0.000 description 2
- 101150111062 C gene Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- -1 for example Substances 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000004627 regenerated cellulose Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 1
- 108010058607 HLA-B Antigens Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 238000002898 library design Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010213721.2 | 2010-06-30 | ||
| CN201010213717.6A CN101921840B (zh) | 2010-06-30 | 2010-06-30 | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 |
| CN 201010213721 CN101921842B (zh) | 2010-06-30 | 2010-06-30 | Hla-a,b基因分型用pcr引物及其使用方法 |
| CN201010213717.6 | 2010-06-30 | ||
| CN201010213719.5A CN101921841B (zh) | 2010-06-30 | 2010-06-30 | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 |
| CN201010213719.5 | 2010-06-30 | ||
| CNPCT/CN2010/002150 | 2010-12-24 | ||
| CNPCT/CN2010/002149 | 2010-12-24 | ||
| PCT/CN2010/002150 WO2012083506A1 (zh) | 2010-12-24 | 2010-12-24 | Hla-dqb1基因分型的方法及其相关引物 |
| PCT/CN2010/002149 WO2012083505A1 (zh) | 2010-12-24 | 2010-12-24 | Hla-c基因分型的方法及其相关引物 |
| PCT/CN2011/076688 WO2012000445A1 (zh) | 2010-06-30 | 2011-06-30 | 新的的pcr测序方法及其在hla基因分型中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2013103795A RU2013103795A (ru) | 2014-08-20 |
| RU2587606C2 true RU2587606C2 (ru) | 2016-06-20 |
Family
ID=45401405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013103795/10A RU2587606C2 (ru) | 2010-06-30 | 2011-06-30 | Новый способ пцр-секвенирования и его применение в генотипировании hla |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9957564B2 (enExample) |
| EP (1) | EP2599877B1 (enExample) |
| JP (1) | JP5968879B2 (enExample) |
| KR (1) | KR101709826B1 (enExample) |
| AU (1) | AU2011274090B2 (enExample) |
| BR (1) | BR112012032586B1 (enExample) |
| CA (1) | CA2803940C (enExample) |
| DK (1) | DK2599877T3 (enExample) |
| MY (1) | MY173793A (enExample) |
| RU (1) | RU2587606C2 (enExample) |
| SG (1) | SG186876A1 (enExample) |
| WO (1) | WO2012000445A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2703394C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| RU2703401C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Тест-система для выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| RU2829344C1 (ru) * | 2023-06-29 | 2024-10-30 | Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) | Способ пробоподготовки образцов для типирования генов главного комплекса гистосовместимости HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, HLA-DRB1 и олигонуклеотидные праймеры для его реализации |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201708498VA (en) | 2013-04-17 | 2017-11-29 | Agency Science Tech & Res | Method for generating extended sequence reads |
| JP6308724B2 (ja) | 2013-05-09 | 2018-04-11 | ジェノダイブファーマ株式会社 | Ｈｌａ遺伝子のマルチプレックスｄｎａタイピング方法及びキット |
| US10508311B2 (en) * | 2013-08-26 | 2019-12-17 | The Translational Genomics Research Institute | Single molecule-overlapping read analysis for minor variant mutation detection in pathogen samples |
| GB201409282D0 (en) | 2014-05-23 | 2014-07-09 | Univ Sydney Tech | Sequencing process |
| CN106661636A (zh) * | 2014-09-05 | 2017-05-10 | 凯杰有限公司 | 衔接子连接的扩增子的制备 |
| WO2016037358A1 (zh) * | 2014-09-12 | 2016-03-17 | 深圳华大基因科技有限公司 | 分离的寡核苷酸及其在核酸测序中的用途 |
| US10233490B2 (en) | 2014-11-21 | 2019-03-19 | Metabiotech Corporation | Methods for assembling and reading nucleic acid sequences from mixed populations |
| US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US10429342B2 (en) | 2014-12-18 | 2019-10-01 | Edico Genome Corporation | Chemically-sensitive field effect transistor |
| US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
| US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
| US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| WO2016124069A1 (zh) * | 2015-02-04 | 2016-08-11 | 深圳华大基因研究院 | 一种构建长片段测序文库的方法 |
| KR101651817B1 (ko) * | 2015-10-28 | 2016-08-29 | 대한민국 | Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트 |
| US20190048413A1 (en) * | 2016-02-23 | 2019-02-14 | Novozymes A/S | Improved next-generation sequencing |
| WO2017201081A1 (en) | 2016-05-16 | 2017-11-23 | Agilome, Inc. | Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids |
| CN110312825A (zh) | 2016-10-24 | 2019-10-08 | 吉内恩福赛克公司 | 隐藏核酸内存在的信息 |
| WO2018093724A1 (en) | 2016-11-15 | 2018-05-24 | Quest Diagnostics Investments Llc | Methods for detecting dna mutations using mitra tip extraction |
| CA3044033A1 (en) | 2016-11-15 | 2018-05-24 | Quest Diagnostics Investments Llc | Methods for detecting cystic fibrosis mutations using mitra tip extraction |
| EP3626835A1 (en) | 2018-09-18 | 2020-03-25 | Sistemas Genómicos, S.L. | Method for genotypically identifying both alleles of at least one locus of a subject's hla gene |
| FR3100820B1 (fr) | 2019-09-12 | 2024-06-28 | Bionobis | Procédé de génotypage adapté au traitement d’un grand nombre d’échantillons, notamment en cas de polymorphisme élevé |
| FR3106596B1 (fr) | 2020-01-27 | 2022-12-02 | Bionobis | Procede de genotypage hla simple et rapide |
| CN111235266B (zh) * | 2020-03-10 | 2023-12-01 | 广州医科大学附属第二医院 | Hla亚型检测试剂盒及其应用 |
| FR3110178B1 (fr) * | 2020-05-18 | 2022-05-27 | Bionobis | Procédé de génotypage adapté au traitement simultané d’un grand nombre de patients |
| CN112553313A (zh) * | 2020-12-30 | 2021-03-26 | 武汉康圣达医学检验所有限公司 | 用于Sanger法的测序反应产物的变性方法 |
| KR102507110B1 (ko) * | 2022-02-15 | 2023-03-07 | 주식회사 네오젠티씨 | 주조직 적합성 복합체의 타입들을 분석하기 위한 방법 및 장치 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580730A (en) * | 1994-08-19 | 1996-12-03 | Olympus America, Inc. | Enzyme digestion method for the detection of amplified DNA |
| US5683872A (en) * | 1991-10-31 | 1997-11-04 | University Of Pittsburgh | Polymers of oligonucleotide probes as the bound ligands for use in reverse dot blots |
| WO1998035059A1 (en) * | 1997-02-11 | 1998-08-13 | Hildebrand William H | Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing |
| WO2005042764A2 (en) * | 2003-10-28 | 2005-05-12 | Dynal Biotech Llc | Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles |
| US7300755B1 (en) * | 2003-05-12 | 2007-11-27 | Fred Hutchinson Cancer Research Center | Methods for haplotyping genomic DNA |
| WO2007140540A2 (en) * | 2006-06-09 | 2007-12-13 | Conexio 4 Pty Ltd | Identification of a nucleic acid molecule |
| WO2009049889A1 (en) * | 2007-10-16 | 2009-04-23 | Roche Diagnostics Gmbh | High resolution, high throughput hla genotyping by clonal sequencing |
| RU2393231C1 (ru) * | 2008-12-29 | 2010-06-27 | Федеральное государственное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ определения генетического родства штаммов холерных вибрионов методом секвенирования генов, фланкирующих кластер генов биосинтеза о-антигена |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953650A1 (en) * | 1998-04-20 | 1999-11-03 | Innogenetics N.V. | Method for typing of HLA alleles |
| DE602004026033D1 (de) | 2003-01-29 | 2010-04-29 | 454 Corp | Zweiendige sequenzierung |
| CA2612145A1 (en) * | 2005-05-10 | 2006-11-16 | Eric A. Johnson | Methods of mapping polymorphisms and polymorphism microarrays |
| EP2703499A1 (en) * | 2005-06-02 | 2014-03-05 | Fluidigm Corporation | Analysis using microfluidic partitioning devices to generate single cell samples |
| CA2910861C (en) * | 2005-09-29 | 2018-08-07 | Michael Josephus Theresia Van Eijk | High throughput screening of mutagenized populations |
| WO2007055568A1 (en) | 2005-11-14 | 2007-05-18 | Keygene N.V. | Method for high throughput screening of transposon tagging populations and massive parallel sequence identification of insertion sites |
| ES2882401T3 (es) * | 2005-12-22 | 2021-12-01 | Keygene Nv | Método de detección de polimorfismos basado en AFLP de alto rendimiento |
| US20100086914A1 (en) * | 2008-10-03 | 2010-04-08 | Roche Molecular Systems, Inc. | High resolution, high throughput hla genotyping by clonal sequencing |
| CN101921840B (zh) | 2010-06-30 | 2014-06-25 | 深圳华大基因科技有限公司 | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 |
| CN101921841B (zh) * | 2010-06-30 | 2014-03-12 | 深圳华大基因科技有限公司 | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 |
| CN101921842B (zh) | 2010-06-30 | 2013-08-07 | 深圳华大基因科技有限公司 | Hla-a,b基因分型用pcr引物及其使用方法 |
-
2011
- 2011-06-30 DK DK11800190.8T patent/DK2599877T3/da active
- 2011-06-30 MY MYPI2012005591A patent/MY173793A/en unknown
- 2011-06-30 SG SG2012096616A patent/SG186876A1/en unknown
- 2011-06-30 RU RU2013103795/10A patent/RU2587606C2/ru active IP Right Revival
- 2011-06-30 CA CA2803940A patent/CA2803940C/en active Active
- 2011-06-30 AU AU2011274090A patent/AU2011274090B2/en active Active
- 2011-06-30 JP JP2013516983A patent/JP5968879B2/ja active Active
- 2011-06-30 US US13/807,660 patent/US9957564B2/en active Active
- 2011-06-30 BR BR112012032586-8A patent/BR112012032586B1/pt active IP Right Grant
- 2011-06-30 EP EP11800190.8A patent/EP2599877B1/en active Active
- 2011-06-30 KR KR1020137002332A patent/KR101709826B1/ko active Active
- 2011-06-30 WO PCT/CN2011/076688 patent/WO2012000445A1/zh not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5683872A (en) * | 1991-10-31 | 1997-11-04 | University Of Pittsburgh | Polymers of oligonucleotide probes as the bound ligands for use in reverse dot blots |
| US5580730A (en) * | 1994-08-19 | 1996-12-03 | Olympus America, Inc. | Enzyme digestion method for the detection of amplified DNA |
| WO1998035059A1 (en) * | 1997-02-11 | 1998-08-13 | Hildebrand William H | Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing |
| US7300755B1 (en) * | 2003-05-12 | 2007-11-27 | Fred Hutchinson Cancer Research Center | Methods for haplotyping genomic DNA |
| WO2005042764A2 (en) * | 2003-10-28 | 2005-05-12 | Dynal Biotech Llc | Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles |
| WO2007140540A2 (en) * | 2006-06-09 | 2007-12-13 | Conexio 4 Pty Ltd | Identification of a nucleic acid molecule |
| WO2009049889A1 (en) * | 2007-10-16 | 2009-04-23 | Roche Diagnostics Gmbh | High resolution, high throughput hla genotyping by clonal sequencing |
| RU2393231C1 (ru) * | 2008-12-29 | 2010-06-27 | Федеральное государственное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ определения генетического родства штаммов холерных вибрионов методом секвенирования генов, фланкирующих кластер генов биосинтеза о-антигена |
Non-Patent Citations (2)
| Title |
|---|
| JEESUK YU ET AL., Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB, Clinical Immunology, 2004, v. 113, p. 318 -325. * |
| STEN LINNARSSON, Recent advances in DNA sequencing methods-general principles of sample preparation, EXPERIMENTAL CELL RESEARCH, 2010, v. 316, no. 8, p. 1339-1343. * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2703394C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| RU2703401C1 (ru) * | 2018-10-24 | 2019-10-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Тест-система для выявления и генотипирования РНК вируса репродуктивно-респираторного синдрома свиней |
| RU2829344C1 (ru) * | 2023-06-29 | 2024-10-30 | Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) | Способ пробоподготовки образцов для типирования генов главного комплекса гистосовместимости HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1, HLA-DRB1 и олигонуклеотидные праймеры для его реализации |
| RU2833819C1 (ru) * | 2024-06-27 | 2025-01-28 | Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) | Способ секвенирования экзонов гена HLA-DQA1 и набор синтетических олигонуклеотидов для его реализации |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013529472A (ja) | 2013-07-22 |
| DK2599877T3 (da) | 2017-11-20 |
| SG186876A1 (en) | 2013-02-28 |
| AU2011274090B2 (en) | 2015-04-09 |
| KR101709826B1 (ko) | 2017-02-24 |
| CA2803940A1 (en) | 2012-01-05 |
| BR112012032586B1 (pt) | 2021-08-17 |
| MY173793A (en) | 2020-02-24 |
| AU2011274090A1 (en) | 2013-02-07 |
| EP2599877B1 (en) | 2017-09-27 |
| JP5968879B2 (ja) | 2016-08-10 |
| WO2012000445A1 (zh) | 2012-01-05 |
| EP2599877A1 (en) | 2013-06-05 |
| US9957564B2 (en) | 2018-05-01 |
| EP2599877A4 (en) | 2014-01-01 |
| CA2803940C (en) | 2019-07-02 |
| KR20130038353A (ko) | 2013-04-17 |
| US20130237432A1 (en) | 2013-09-12 |
| RU2013103795A (ru) | 2014-08-20 |
| BR112012032586A2 (pt) | 2019-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9957564B2 (en) | Application of a PCR sequencing method, based on DNA barcoding technique and DNA incomplete shearing strategy, in HLA genotyping | |
| CN101921840B (zh) | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 | |
| CN101921841B (zh) | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 | |
| CN101921842B (zh) | Hla-a,b基因分型用pcr引物及其使用方法 | |
| WO2012037883A1 (zh) | 核酸标签及其应用 | |
| CN116179671A (zh) | 一种用于hla基因分型的扩增引物组、试剂盒及方法 | |
| WO2017135396A1 (ja) | Ｐｃｒを用いないキャプチャー法によるｈｌａ遺伝子タイピング用プローブセット及びそれを用いたタイピング方法 | |
| CN108060227A (zh) | 一种检测pah基因突变的扩增引物、试剂盒及其检测方法 | |
| JP2022002539A (ja) | 主要組織適合遺伝子複合体一塩基多型 | |
| CN103270170B (zh) | Hla-dqb1基因分型的方法及其相关引物 | |
| Kulski et al. | In phase HLA genotyping by next generation sequencing—a comparison between two massively parallel sequencing bench-top Systems, the Roche GS Junior and Ion Torrent PGM | |
| TWI542696B (zh) | HLA - C genotyping and its related primers | |
| ES2347738T3 (es) | Procedimiento para la determinacion de locus del antigeno clase ii de histocompatibilidad. | |
| CN114540486A (zh) | 一种hla-dpa1基因全长扩增引物组、分型试剂盒 | |
| CN109957615B (zh) | 一种单细胞基因组目标区域捕获的方法 | |
| JP2026054426A (ja) | キャプチャー法による多検体ｈｌａ遺伝子タイピング用プローブセット及びそれを用いたタイピング方法 | |
| HK1185115B (en) | Method for hla-dqb1 genotyping and related primers thereof | |
| HK1185114B (en) | Method for hla-c genotyping and related primers thereof | |
| HK1148788A (en) | An illumina paired-end sequencing based pcr-barcoded amplicon fragments sequencing method | |
| HK1148788B (en) | An illumina paired-end sequencing based pcr-barcoded amplicon fragments sequencing method | |
| HK1148787A1 (en) | Pcr primers for hla-a,b genotyping and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant | ||
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170701 |
|
| NF4A | Reinstatement of patent |
Effective date: 20180206 |